Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV003460767 | SCV004190215 | benign | RPE65-related recessive retinopathy | 2023-12-22 | reviewed by expert panel | curation | NM_000329.3(RPE65):c.1155G>A (p.Thr385=) is a synonymous variant at codon 385. The splicing impact predictor SpliceAI gives a delta score of 0.00, which is below the ClinGen LCA / eoRD VCEP recommended threshold of <0.1 and does not predict an impact on splicing (BP4, BP7). This variant is present in gnomAD v.2.1.1 at a GrpMax allele frequency of 0.01596, with 704 alleles / 41408 total alleles in the African/African American population, which is higher than the ClinGen LCA / eoRD VCEP BA1 threshold of >0.008 (BA1). In summary, this variant meets the criteria to be classified as benign for RPE65-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA/eoRD VCEP: BA1, BP4, BP7. (VCEP specifications version 1.0.0; date of approval 09/21/2023). |
Counsyl | RCV000666107 | SCV000790349 | likely benign | Leber congenital amaurosis 2; Retinitis pigmentosa 20 | 2017-03-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000666107 | SCV001021784 | benign | Leber congenital amaurosis 2; Retinitis pigmentosa 20 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001098671 | SCV001255054 | benign | Leber congenital amaurosis 2 | 2017-09-15 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV001098672 | SCV001255055 | benign | Retinitis pigmentosa | 2017-09-15 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Gene |
RCV000085153 | SCV001945759 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002498449 | SCV002812433 | likely benign | Leber congenital amaurosis 2; Retinitis pigmentosa 20; Retinitis pigmentosa 87 with choroidal involvement | 2021-09-27 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000085153 | SCV005258572 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Retina International | RCV000085153 | SCV000117290 | not provided | not provided | no assertion provided | not provided | ||
Clinical Genetics, |
RCV001699203 | SCV001924910 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000085153 | SCV001975891 | likely benign | not provided | no assertion criteria provided | clinical testing |